Ventrus Biosciences Announces Full Exercise of Overallotment Option by Underwriters

[at noodls] – NEW YORK, Feb. 7, 2013 (GLOBE NEWSWIRE) — Ventrus Biosciences, Inc. (Nasdaq:VTUS) today announced that the underwriter of its previously announced public offering of common stock has exercised in full … more

View todays social media effects on VTUS

View the latest stocks trending across Twitter. Click to view dashboard

See who Ventrus is hiring next, click here to view